Hello!
Our institution has seen an increase in hypersensitivity reactions to Cabenuva injections in recent months. Nurses also note that the rilpivirine is “thick” when administering. Wondering if any other institutions have seen an increase in these reactions.
Kristen Hughes, PharmD, BCPS, CPPS
Clinical Pharmacist, Medication Safety and Informatics
Division of Pharmaceutical Services
Department of Pharmacy and Pharmaceutical Sciences
St. Jude Children's Research Hospital
Email: kristen.hughes@stjude.org